Bristol-Myers Squibb BMY reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Bristol-Myers Squibb beat estimated earnings by 6.04%, reporting an EPS of $1.93 versus an estimate of $1.82.
Revenue was up $184.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 2.5% drop in the share price the next day.
Here's a look at Bristol-Myers Squibb's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 1.91 | 1.80 | 1.92 | 1.91 |
EPS Actual | 1.96 | 1.83 | 2 | 1.93 |
Revenue Estimate | 11.36B | 12.08B | 11.58B | 11.33B |
Revenue Actual | 11.65B | 11.98B | 11.62B | 11.70B |
To track all earnings releases for Bristol-Myers Squibb visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.